New Therapy Targets Skin and Atherosclerosis in Psoriasis Medscape March 20, 2012 (San Diego, California) — A novel spoken immune modulator, known As VB-201, simultaneously improved psoriatic skin lesions and ablated atherosclerotic plaque in type A phase 2 study, according to results reported here at the American lyceum ... Link To Article
No comments:
Post a Comment